We serve Chemical Name:6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one CAS:848170-40-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one
CAS.NO:848170-40-1
Synonyms:6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one
Molecular Formula:C12H11BrClNO
Molecular Weight:300.57900
HS Code:2933790090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:32.86000
Exact Mass:298.97100
LogP:3.46200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one Use and application,6-bromo-3-(3-chloropropyl)-1H-quinolin-2-one technical grade,usp/ep/jp grade.
Related News: Bluebird determined that death was highly unlikely to have been caused by the delivery virus used in both Zynteglo and LentiGlobin. (ethoxy-d5)(phenyl)zinc manufacturers Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.” 3′-azido-3′-deoxythymidine 5-carbonylbisphosphonate suppliers Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.” 6-(4-((2-fluorobenzyl)oxy)-2-methylbenzofuran-6-carboxamido)nicotinic acid vendor & factory But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.,GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said.
